|
Real-time Estimate
Cboe BZX
03:19:09 26/08/26 am AEST
|
5-day change | 1st Jan Change | ||
| 9.115 USD | +4.89% |
|
+0.06% | -13.38% |
| 09:30pm | Immatics Announces $150 Million Underwritten Offering | MT |
| 18/08 | Immatics' Q2 Net Loss Narrows as Revenue Rises | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IMMATICS N.V. | Bio Therapeutic Drugs | +4.49% | +0.06% | -13.38% | +73.90% | -24.46% | 1.19B |  | | |
- Stock Market
- Stocks
- IMTX Stock
- Charts Immatics N.V.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
